CANTALOUPE, INC. Income Taxes Disclosure
| Year ended June 30, | |||||||||||||||||
| ($ in thousands) | 2025 | 2024 | 2023 | ||||||||||||||
| Current: | |||||||||||||||||
| Federal | $ | — | $ | (65) | $ | — | |||||||||||
| State | (1,368) | (729) | (92) | ||||||||||||||
| Foreign | — | — | — | ||||||||||||||
| Total current | (1,368) | (794) | (92) | ||||||||||||||
| Deferred: | |||||||||||||||||
| Federal | 40,092 | (248) | (62) | ||||||||||||||
| State | 3,628 | 57 | (27) | ||||||||||||||
| Foreign | — | — | — | ||||||||||||||
| Total deferred | 43,720 | (191) | (89) | ||||||||||||||
| Total income tax benefit (provision) | $ | 42,352 | $ | (985) | $ | (181) | |||||||||||
| Year ended June 30, | |||||||||||||||||
| ($ in thousands) | 2025 | 2024 | 2023 | ||||||||||||||
| U.S. income | $ | 26,489 | $ | 16,217 | $ | 996 | |||||||||||
| Foreign losses | (4,308) | (3,239) | (182) | ||||||||||||||
| Total pre-tax income | $ | 22,181 | $ | 12,978 | $ | 814 | |||||||||||
| Year ended June 30, | |||||||||||||||||
| ($ in thousands) | 2025 | 2024 | 2023 | ||||||||||||||
Tax at U.S Federal statutory rate | $ | (4,658) | $ | (2,725) | $ | (171) | |||||||||||
| Effects of permanent differences | |||||||||||||||||
| Stock compensation | $ | 90 | $ | 24 | $ | (688) | |||||||||||
| Other permanent differences | $ | 56 | $ | (81) | $ | (497) | |||||||||||
| State income taxes, net of federal benefit | $ | (1,172) | $ | (613) | $ | (296) | |||||||||||
| Changes related to prior fiscal years | $ | (603) | $ | — | $ | 51 | |||||||||||
| Changes related to state tax rates | $ | 67 | $ | — | $ | (2,455) | |||||||||||
| Changes in valuation allowances | $ | 48,221 | $ | 2,281 | $ | 3,942 | |||||||||||
Statutory Rates Different from U.S. | $ | 262 | $ | 183 | $ | — | |||||||||||
| Other | $ | 89 | $ | (54) | $ | (67) | |||||||||||
Total | $ | 42,352 | $ | (985) | $ | (181) | |||||||||||
| As of June 30, | |||||||||||
| ($ in thousands) | 2025 | 2024 | |||||||||
| Deferred tax assets: | |||||||||||
| Net operating loss carryforwards | $ | 32,435 | $ | 37,621 | |||||||
| Receivable credit losses | 1,208 | 1,367 | |||||||||
| Inventory reserves | 614 | 541 | |||||||||
| Sales returns and allowances | 2,410 | 2,463 | |||||||||
| Sales tax reserves | 1,213 | 1,876 | |||||||||
| Deferred research and development | 7,997 | 5,750 | |||||||||
| Stock-based compensation | 4,564 | 4,327 | |||||||||
| Lease liabilities | 2,397 | 2,410 | |||||||||
| Other | — | 346 | |||||||||
| 52,838 | 56,701 | ||||||||||
| Deferred tax liabilities: | |||||||||||
| Intangibles | (3,154) | (3,502) | |||||||||
| Property and equipment | (17) | (1,179) | |||||||||
| Right-of-use assets | (1,847) | (1,954) | |||||||||
| Other | (52) | — | |||||||||
| (5,070) | (6,635) | ||||||||||
| Deferred tax assets, net | 47,768 | 50,066 | |||||||||
| Valuation allowance | (4,515) | (50,532) | |||||||||
| Deferred income taxes | $ | 43,253 | $ | (466) | |||||||
| Year ended June 30, | |||||||||||||||||
| ($ in thousands) | 2025 | 2024 | 2023 | ||||||||||||||
| Balance at the beginning of the year | $ | 799 | $ | 689 | $ | 572 | |||||||||||
| Gross increases and decreases related to current period tax positions | — | — | — | ||||||||||||||
| Gross increases and decreases related to prior period tax positions | (112) | 110 | 117 | ||||||||||||||
| Balance at the end of the year | $ | 687 | $ | 799 | $ | 689 | |||||||||||
The Company files income tax returns in the United States, various states, and international jurisdictions. The tax years ended June 30, 2022 through June 30, 2024 remain open to examination by taxing jurisdictions. While the statute of limitations has expired for years prior to the year ended June 30, 2022, changes in reported losses for those years are subject to examination by tax authorities to the extent that operating loss carryforwards from those prior fiscal years impact upon taxable income in current years. As of June 30, 2025, the Company did not have any income tax examinations in process.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Sep 8, 2025 | Showing above |
| 2024 | Sep 10, 2024 | |
| 2023 | Sep 25, 2023 | |
| 2021 | Sep 3, 2021 | |
| 2020 | Sep 11, 2020 | |
| 2019 | Oct 9, 2019 | |
| 2017 | Aug 23, 2017 | |
| 2016 | Sep 13, 2016 | |
| 2015 | Sep 30, 2015 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.